Augmenting varenicline treatment with transcranial direct current stimulation (tDCS) increases smoking abstinence rates at end of treatment

• Helena Zhang,
• Tarek K. Rajji,
• Peter Selby,
• Osnat Melamed,
• Sophia Attwells,
• Laurie Zawertailo

Affiliations

Helena Zhang

Nicotine Dependence Service, Addictions Program, Centre for Addiction and Mental Health, Toronto, Canada; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Canada

Tarek K. Rajji

Department of Psychiatry, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada

Peter Selby

Nicotine Dependence Service, Addictions Program, Centre for Addiction and Mental Health, Toronto, Canada; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada

Osnat Melamed

Nicotine Dependence Service, Addictions Program, Centre for Addiction and Mental Health, Toronto, Canada

Sophia Attwells

Nicotine Dependence Service, Addictions Program, Centre for Addiction and Mental Health, Toronto, Canada

Laurie Zawertailo

Corresponding author. Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, ON, Canada.; Nicotine Dependence Service, Addictions Program, Centre for Addiction and Mental Health, Toronto, Canada; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada